﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Tue, 14 Apr 2026 20:08:49 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/July-2025/rss/3733</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/July-2025/rss/3733" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Trending Topics]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/trending-topics-28</link><description><![CDATA[  APhA Staff  

 Researchers evaluate safety of daptomycin coadministered with statins 

   

 Conflicting clinical evidence and prescribing recommendations exist regarding the safety of ...]]></description><pubDate>Sat, 07 Jun 2025 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/trending-topics-28</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3468]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Pharmacist-led diabetes management improves outcomes and lowers costs]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/pharmacist-led-diabetes-management-improves-outcomes-and-lowers-costs</link><description><![CDATA[  Sonya Collins  

   

 More than 38 million adults in the United States have diabetes, with the highest prevalence among people of color. Besides the toll it takes on health, quality of life, ...]]></description><pubDate>Sat, 07 Jun 2025 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/pharmacist-led-diabetes-management-improves-outcomes-and-lowers-costs</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3462]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Research provides clarity on how steroid dose and timing influence leukocytosis]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/research-provides-clarity-on-how-steroid-dose-and-timing-influence-leukocytosis</link><description><![CDATA[  Aiya Almogaber, PharmD  

   

 Corticosteroids, widely used in inpatient settings to manage inflammation, are known to elevate white blood cell counts, but the extent and timing of that effect ...]]></description><pubDate>Sat, 07 Jun 2025 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/research-provides-clarity-on-how-steroid-dose-and-timing-influence-leukocytosis</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3463]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Oral semaglutide offers cardiovascular benefits in high-risk T2D]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/oral-semaglutide-offers-cardiovascular-benefits-in-high-risk-t2d</link><description><![CDATA[  Sonya Collins  

   

 Last year, FDA approved injectable semaglutide (Wegovy) to reduce the risk of cardiovascular death, heart attack, and stroke in people with CVD and obesity or overweight. ...]]></description><pubDate>Sat, 07 Jun 2025 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/oral-semaglutide-offers-cardiovascular-benefits-in-high-risk-t2d</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3465]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Study findings suggest DOACs are favorable treatment option for CVT]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/study-findings-suggest-doacs-are-favorable-treatment-option-for-cvt</link><description><![CDATA[  Corey Diamond, PharmD  

   

 Comparing outcomes between direct oral anticoagulant (DOAC) and vitamin K antagonist users across a large, multinational cohort, researchers found no significant ...]]></description><pubDate>Sat, 07 Jun 2025 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/study-findings-suggest-doacs-are-favorable-treatment-option-for-cvt</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3466]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Naltrexone for alcohol use disorder may work for hospitalized patients]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/naltrexone-for-alcohol-use-disorder-may-work-for-hospitalized-patients</link><description><![CDATA[  Deborah Russell-Brown  

   

 Naltrexone has been a successful treatmeant for alcohol use disorder and other related disorders for a long time. However, its popularity has come against a ...]]></description><pubDate>Sat, 07 Jun 2025 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/naltrexone-for-alcohol-use-disorder-may-work-for-hospitalized-patients</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3467]]></dc:identifier></item></channel></rss>